Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001033427-16-000083
Filing Date
2016-01-26
Accepted
2016-01-26 11:21:08
Documents
1
Group Members
DAVID L. COHENHAROLD J. LEVY

Document Format Files

Seq Description Document Type Size
1 myriad13ga112312015.htm SC 13G/A 94637
  Complete submission text file 0001033427-16-000083.txt   96119
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Subject) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48577 | Film No.: 161360508
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 276 POST ROAD WEST WESTPORT CT 06880-4704
Business Address 276 POST ROAD WEST WESTPORT CT 06880-4704 2033417800
IRIDIAN ASSET MANAGEMENT LLC/CT (Filed by) CIK: 0001033427 (see all company filings)

EIN.: 061439577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A